Goosehead Insurance vs Ethos Technologies
GSHD and LIFE side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GSHD and LIFE compare
Ethos Technologies is the larger company, worth 1.2 times as much as Goosehead Insurance ($2.1B against $1.8B).
On earnings, Ethos Technologies is cheaper: it trades at 26.9× trailing earnings, against 48.2× for Goosehead Insurance.
Ethos Technologies grew revenue faster over the last twelve months (52.0% versus 17.7% for Goosehead Insurance).
Ethos Technologies keeps more of each dollar of sales as profit, with a net margin of 18.4% compared with 8.8% at Goosehead Insurance.
Goosehead Insurance scores higher on the StockData Score (11 against 9 for Ethos Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GSHD | LIFE |
|---|---|---|
| Size and price | ||
| Market cap | $1.8B | $2.1B |
| Share price | $49.64 | $32.80 |
| Change, 1 year | −28.1% | 1626% |
| Change, 5 years | −63.3% | – |
| Beta (5Y) | −0.70 | – |
| Employees | 1,000 | 614 |
| StockData Score | ||
| Total score | 11 (better) | 9 |
| Valuation score | 1 | 2 (better) |
| Growth score | 4 (better) | 3 |
| Performance score | 4 (better) | 3 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 48.2× | 26.9× (better) |
| P/S | 4.4× (better) | 5.4× |
| P/B | – | 4.4× |
| EV/EBITDA | 18.6× (better) | 24.6× |
| P/FCF | 22.1× (better) | 60.2× |
| PEG | 0.21 | – |
| FCF yield | 4.5% (better) | 1.7% |
| Fair value | – | $33.82 |
| Margin of safety | – | 3.0% |
| Growth | ||
| Revenue growth (TTM) | 17.7% | 52.0% (better) |
| Revenue growth, 5Y average | 25.6% | – |
| Net income growth (TTM) | 18.0% | 45.7% (better) |
| EPS growth (TTM) | 8.4% | 43.5% (better) |
| EPS growth, 5Y average | 15.3% | – |
| Profitability | ||
| Gross margin | – | 98.3% |
| Operating margin | 23.3% (better) | 18.8% |
| Net margin | 8.8% | 18.4% (better) |
| FCF margin | 19.8% (better) | 9.0% |
| Return on equity | – | 38.6% |
| Return on invested capital | 51.3% | 141% (better) |
| Financial health | ||
| Net debt / EBITDA | 2.77 | – |
| Interest coverage | 4.1× | – |
| Current ratio | 1.54 (better) | 1.52 |
| Altman Z-score | 3.21 | 6.28 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | – |
| Payout ratio | – | 0.00% |
| Buyback yield | 7.7% | – |
| Shareholder yield | 7.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 73.1% | 27.7% |
| Held by insiders | 62.9% | 74.7% |
| Insider net buying, 12 months | −$14.8M (better) | −$89.6M |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 18.7% | 22.8% |
Go deeper
- GSHD stock overview
- GSHD income statement
- GSHD valuation and score
- LIFE stock overview
- LIFE income statement
- LIFE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.